Impact of introducing sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes without complications

被引：0

作者：

Mehta, R. ^{[1
]}

Bahia, L. ^{[2
]}

Saif, A. ^{[3
]}

Musso, C. ^{[4
]}

Deyneli, O. ^{[5
]}

Subramaniam, S. ^{[6
]}

Gabriel, Z. ^{[7
]}

Goncalves, S. ^{[8
]}

Solorzano, J. ^{[9
]}

Vasnawala, H. ^{[10
]}

Schabert, V. ^{[11
]}

Mihajlovic, J. ^{[12
]}

机构：

[1] Natl Inst Med Sci & Nutr Salvador Zubiran, INCMNSZ, Dept Endocrinol & Metab, Mexico City, DF, Mexico

[2] Univ Estado Rio De Janeiro, Natl Inst Hlth Technol Assessment, Rio De Janeiro, Brazil

[3] Cairo Univ, Dept Internal Med, Cairo, Egypt

[4] Hosp Univ Fdn Favaloro, Diabet Metab Dept, Buenos Aires, DF, Argentina

[5] Koc Univ, Sch Med, Endocrinol Sect, Istanbul, Turkiye

[6] Klin & Surg Bukit Rimau, Dept Family Med, Shah Alam, Malaysia

[7] AstraZeneca, CVRM & R&I Int Reg, Luton, Beds, England

[8] AstraZeneca, CVRM Int Reg, Buenos Aires, DF, Argentina

[9] AstraZeneca, CVRM Int Reg, San Jose, Costa Rica

[10] AstraZeneca, CVRM Int Reg, Bengaluru, India

[11] Epilogix LLC, Sarajevo, Bosnia & Herceg

[12] Mihajlovic Hlth Analyt, Novi Sad, Serbia

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2023年 / 197卷

关键词：

D O I：

10.1016/j.diabres.2023.110480

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

IDF2022-05

引用

页数：2

共 50 条

[1] Sodium-glucose cotransporter-2 inhibitors in patients without diabetes
Fryml, Elise
Lanktree, Matthew B.
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (17) : E619 - E619
[2] Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes
Chilton, Robert J.
[J]. DIABETES OBESITY & METABOLISM, 2020, 22 (01): : 16 - 29
[3] Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With CKD and Type 2 Diabetes
Fu, Edouard
D'Andrea, Elvira
Wexler, Deborah J.
Patorno, Elisabetta
Paik, Julie M.
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 673 - 673
[4] Sodium-glucose cotransporter-2 inhibitors and fractures in type 2 diabetes mellitus
Pavlicek, Vojtech
[J]. DIABETOLOGE, 2022, 18 (02): : 198 - 199
[5] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis
Anan, Go
Kikuchi, Daisuke
Hirose, Takuo
Ito, Hiroki
Nakayama, Shingo
Mori, Takefumi
[J]. KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 925 - 928
[6] Perioperative Considerations for the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes
Peacock, Sharon C.
Lovshin, Julie A.
Cherney, David Z. I.
[J]. ANESTHESIA AND ANALGESIA, 2018, 126 (02): : 699 - 704
[7] Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
Handelsman, Yehuda
[J]. ADVANCES IN THERAPY, 2019, 36 (10) : 2567 - 2586
[8] Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
Yehuda Handelsman
[J]. Advances in Therapy, 2019, 36 : 2567 - 2586
[9] Cardiovascular Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Type 2 Diabetes
Woo, Vincent C.
[J]. CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 61 - 67
[10] Patients with diabetes with and without sodium-glucose cotransporter-2 inhibitors use with incident cancer risk
Hu, Wei-Syun
Lin, Cheng-Li
[J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (05)

← 1 2 3 4 5 →